Genenta Science Income Statement

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Quarter	H2 2025	H1 2025	H2 2024	H1 2024	H2 2023	H1 2023	H2 2022	H1 2022	H2 2021	H1 2021	H2 2020	H1 2020
Period Ending	Dec '25 Dec 31, 2025	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Jun '24 Jun 30, 2024	Dec '23 Dec 31, 2023	Jun '23 Jun 30, 2023	Dec '22 Dec 31, 2022	Jun '22 Jun 30, 2022	Dec '21 Dec 31, 2021	Jun '21 Jun 30, 2021	Dec '20 Dec 31, 2020	Jun '20 Jun 30, 2020
Selling, General & Admin	-	1.93	-	2.48	2.38	2.88	3.19	2.51	1.45	0.84	0.5	0.4
Research & Development	-	1.45	-	2.04	2.55	3.92	3.7	1.64	0.19	3.2	2.62	2.07
Total Operating Expenses	0	3.38	0	4.52	4.93	6.8	6.89	4.15	1.65	4.04	3.11	2.48
Operating Income	-	-3.38	-	-4.52	-4.93	-6.8	-6.89	-4.15	-1.65	-4.04	-3.11	-2.48
Interest Income	0.34	0.15	0.37	0.15	0.23	0.08	0.04	-	-0.01	-	-0.01	-
Other Non-Operating Income (Expense)	0.05	-0.59	0.09	0.33	-0.07	-0.04	0.7	2.04	0.18	-0.01	0.01	-0
Total Non-Operating Income (Expense)	0.39	-0.44	0.46	0.48	0.16	0.04	0.74	2.04	0.17	-0.01	0	-0
Pretax Income	3.77	-3.83	0.46	-4.04	-4.89	-6.76	-6.37	-2.11	-1.48	-4.05	-3.11	-2.48
Net Income	3.77	-3.83	0.46	-4.04	-4.89	-6.76	-6.37	-2.11	-1.48	-4.05	-3.11	-2.48
Net Income to Common	3.77	-3.83	0.46	-4.04	-4.89	-6.76	-6.37	-2.11	-1.48	-4.05	-3.11	-2.48
Net Income Growth (YoY)	719.88%	-	-	-	-	-	-	-	-	-	-	-
Shares Outstanding (Basic)	21	19	18	18	18	18	18	18	15	15	-	14
Shares Outstanding (Diluted)	21	19	18	18	18	18	18	18	15	15	-	14
Shares Change (YoY)	12.91%	2.80%	0.40%	0.22%	0.00%	-	18.33%	23.32%	-	5.23%	-	-
EPS (Basic)	-0.13	-0.20	-0.27	-0.22	-0.27	-0.37	-0.35	-0.12	-0.10	-0.27	0.18	-0.18
EPS (Diluted)	-0.13	-0.20	-0.27	-0.22	-0.27	-0.37	-0.35	-0.12	-0.10	-0.27	0.18	-0.18
EPS Growth (YoY)	-	-	-	-	-	-	-	-	-	-	-	-
EBIT	-	-3.38	-	-4.52	-4.93	-6.8	-6.89	-4.15	-1.65	-4.04	-3.11	-2.48

SEC Filings: 10-K · 10-Q